More Epsilon Healthcare Limited news
Epsilon Healthcare LimitedASX: EPN

Production commenced to support 6000 Australian Patients

Mar 2, 2020 at 10:17 PM EST · Issued by Epsilon Healthcare Limited

Filed with ASX · Mar 2, 2020 at 10:17 PM EST

On 6ix: 6ix.com/news/production-commenced-to-support-6000-australian-patients

Epsilon Healthcare Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Epsilon Healthcare Limited on 6ix

Story so far

  • First Australian Patients Prescribed Endoca CBD ProductsNov 2, 2018
  • Australian Patients Can Now Access Endoca Medicinal CannabisJul 31, 2018

Earlier from Epsilon Healthcare

  • Launch of Australian and International Medicines SupplyFeb 9, 2020
  • TGA GMP Manufacturing Licence Granted for Southport FacilityJan 20, 2020
  • Product Supply Agreement Signed with MGC PharmaJan 19, 2020
  • First Medicinal Cannabis Processed at Southport FacilityDec 3, 2019
  • THC Global Shareholder UpdateNov 19, 2019

Later from Epsilon Healthcare

  • Medicinal Cannabis Australian Release and Export UpdateApr 21, 2020
  • THC Global Secures $4m Debt FacilityApr 30, 2020
  • THC Global acquires leading clinic network Tetra HealthMay 12, 2020
  • THC Global cannabis product available via prescriptionMay 20, 2020
  • THC Global Investor Presentation - June 2020Jun 11, 2020
All Epsilon Healthcare news releases↗

Follow Epsilon Healthcare into a list and get an email when it puts out news.

Follow Epsilon Healthcare
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer